| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |